Stepwise immunologic selection of antigenic variants during tumor growth

Area of Science:

• Immunology
• Cancer Biology
• Tumor Microenvironment

Background:

• Tumor progression involves complex interactions between cancer cells and the host immune system.
• Ultraviolet (UV)-induced tumors provide a model to study immune evasion during continuous growth.
• Understanding tumor immunologic changes is crucial for developing effective cancer therapies.

Purpose of the Study:

• To investigate the immunologic alterations in tumor cells during sustained growth within a host.
• To identify the sequence of immune escape mechanisms employed by progressing tumors.
• To explore potential strategies for preventing the outgrowth of immunoselected tumor variants.

Main Methods:

• Utilized a highly immunogenic UV-induced tumor model in mice.
• Employed tumor-specific effector cells (macrophages, cytolytic T cells) as probes.
• Analyzed serial reisolates from continuously growing tumors for immunologic changes.
• Generated tumor variants in vitro to predict in vivo evolution.

Main Results:

• Progressor variants with reduced immunogenicity emerged from the continuously growing tumor.
• Tumor cells sequentially developed resistance to activated macrophages and lost tumor-specific antigens.
• The observed sequence of antigen loss was consistent across independent experiments.
• A hierarchy in the host immune response appeared to dictate the order of antigen loss.

Conclusions:

• Tumor cells undergo a predictable sequence of immune escape, involving resistance to macrophages and loss of tumor antigens.
• The host immune response hierarchy influences the selection of tumor variants.
• Generating predicted variants in vitro may offer a method to prevent in vivo tumor outgrowth.